Aquestive Therapeutics, Inc. (AQST)

NASDAQ: AQST · Real-Time Price · USD

3.830

-0.050 (-1.29%)

At close: Feb 18, 2026, 4:00 PM EST

3.820

-0.010 (-0.26%)

After-hours: Feb 18, 2026, 7:54 PM EST

Aquestive Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	467	325	135	49	156	180
Market Cap Growth	69.70%	140.67%	176.07%	-68.73%	-13.14%	-3.55%
Enterprise Value	380	284	155	85	169	229
Last Close Price	3.83	3.56	2.02	0.90	3.89	5.35
PS Ratio	10.77	5.64	2.67	1.02	3.07	3.92
PB Ratio	-	-5.40	-1.27	-0.41	-1.90	-3.71
EV/Sales Ratio	8.75	4.93	3.06	1.79	3.32	4.99
Debt / Equity Ratio	-10.07	-0.63	-0.31	-0.48	-0.69	-0.83
Net Debt / Equity Ratio	21.34	0.56	-0.09	-0.25	-0.35	-0.18
Net Debt / EBITDA Ratio	1.59	1.12	-0.69	-0.76	-0.90	-0.22
Net Debt / FCF Ratio	1.72	0.93	-1.28	-2.79	-0.84	-0.19
Asset Turnover	0.32	0.73	0.88	0.80	0.81	0.65
Inventory Turnover	2.31	2.79	3.32	3.95	4.61	4.87
Quick Ratio	5.51	4.18	1.77	0.81	1.83	1.84
Current Ratio	5.93	4.68	2.24	1.01	2.15	2.12
Return on Assets (ROA)	-25.50%	-24.21%	-16.49%	-44.16%	-34.71%	-37.93%
Return on Capital Employed (ROCE)	-40.40%	-37.30%	-38.60%	-239.80%	-86.60%	-102.70%
Earnings Yield	-14.76%	-13.60%	-5.83%	-111.37%	-45.15%	-31.01%
FCF Yield	-10.90%	-11.07%	-5.47%	-22.20%	-21.69%	-25.56%
Buyback Yield / Dilution	-22.87%	-41.58%	-25.69%	-27.99%	-13.15%	-32.71%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q